0000899243-18-008417.txt : 20180322
0000899243-18-008417.hdr.sgml : 20180322
20180322213651
ACCESSION NUMBER: 0000899243-18-008417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180320
FILED AS OF DATE: 20180322
DATE AS OF CHANGE: 20180322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRACHMAN JONATHAN G
CENTRAL INDEX KEY: 0001588467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 18708237
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-20
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001588467
DRACHMAN JONATHAN G
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
See Remarks
Non-qualified Stock Option (Right to buy)
34.20
2018-03-20
4
A
0
10526
0.00
A
2026-05-09
Common Stock
10526
10526
D
On May 9, 2016, the reporting person was granted an option to purchase 10,526 options of common stock. The performance criteria for this grant were met as of March 20, 2018 and the option shall vest in four (4) equal tranches on the first, second, third and fourth anniversaries of March 20, 2018 subject to continuous service with the Company as of each vesting date.
CMO & EVP, Research & Development
/s/ Jean Liu
2018-03-22